Prevention and treatment of sub-clinical PCVD

作者: Knut Elbers , Francois Xavier Orveillon , Vicky Fachinger , Isabelle Freiin Von Richthofen , Axel Lischewski

DOI:

关键词:

摘要: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for prevention and treatment sub-clinical PCV2 infection in animals, preferably pigs.

参考文章(278)
Charles L. Stoltenow, Getting the Most Out of a Vaccine Program ,(2005)
Changsun Choi, Chanhee Chae, Yooncheol Ha, Kwonil Jung, Junghyun Kim, Enteritis associated with porcine circovirus 2 in pigs Canadian Journal of Veterinary Research-revue Canadienne De Recherche Veterinaire. ,vol. 68, pp. 218- 221 ,(2004)
John C. S. Harding, John A. Ellis, G. Clark, Phil I. Willson, John H. Strokappe, Postweaning multisystemic wasting syndrome: Epidemiology and clinical presentation Journal of Swine Health and Production. ,vol. 6, pp. 249- 254 ,(1998)
A. Lesk, Computational molecular biology Oxford University Press, Inc.. ,(1988)
Mike Muirhead, Sources of information on PMWS/PDNS. Veterinary Record. ,vol. 150, pp. 456- 456 ,(2002)
Eileen L. Thacker, Immunology of the Porcine Respiratory Disease Complex Veterinary Clinics of North America: Food Animal Practice. ,vol. 17, pp. 551- 565 ,(2001) , 10.1016/S0749-0720(15)30006-2
D. E. S. Stewart-Tull, The theory and practical application of adjuvants J. Wiley. ,(1995)
Danny W. Chladek, Louis L. Harris, David E. Gorcyca, Method of growing and attenuating a viral agent associated with mystery swine disease ,(1994)